Invaplex 50 Vaccine Dose-Ranging

This study has been completed.

Sponsor:

Information provided by:

Walter Reed Army Institute of Research (WRAIR)

ClinicalTrials.gov Identifier:

NCT00082069

First received: April 28, 2004

Last updated: January 7, 2010

Last verified: January 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	November 2006
Primary Completion Date:	November 2006 (Final data collection date for primary outcome measure)

No publications provided by Walter Reed Army Institute of Research (WRAIR)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Tribble D, Kaminski R, Cantrell J, Nelson M, Porter C, Baqar S, Williams C, Arora R, Saunders J, Ananthakrishnan M, Sanders J, Zaucha G, Turbyfill R, Oaks E. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers. Vaccine. 2010 Aug 23;28(37):6076-85. Epub 2010 Jul 7.

To Top